Biotechnology Innovation Organization (BIO) is a leading organization based in Washington, DC, dedicated to championing the development and accessibility of innovative treatments for patients with serious medical conditions. With a focus on promoting policies that foster innovation and improve patient access, BIO actively engages in patient advocacy, addressing human health concerns, and advocating for the cost and value of biopharmaceuticals. Additionally, BIO plays a crucial role in advancing the bioeconomy, strengthening global markets and trade, and protecting intellectual property rights.
BIO offers membership options for various sectors, including human health, startups, agriculture, and environment, providing members with a voice in shaping policies and benefiting from sector-specific resources and savings. Through its programs and initiatives, BIO supports workforce development, diversity, and inclusion, aiming to create a more globally competitive biotechnology industry. With a strong emphasis on media engagement, BIO delivers daily news at the intersection of biotechnology, politics, patients, and the planet, while also offering educational webinars and hosting industry-leading events like the BIO International Convention and BIO Partnering JPM Week.
Generated from the website